By increasing Ca 2+ influx and consequently insulin granule exocytosis, both pathways work together to promote insulin secretion
The evidence is preclinical (mouse and cell studies)
Peptides for aging addresses age-specific considerations
Overall, these findings demonstrate that Cagrilintide exerts potent, RAMP-dependent effects on food intake, body weight, and neuronal activation
It should not be presented as an approved medicine for obesity, weight management, diabetes, fatty liver disease, muscle loss, ageing or another medical condition
One deals with the inflammation and signals